Judge blocks HHS' 340B rebate pilot at 11th hour
A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
Newsletters and Deep Dive digital magazine
A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
FDA has turned down Sanofi's oral BTK inhibitor tolebrutinib for multiple sclerosis, despite suggesting earlier it would delay a decision until 2026.
More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.
CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.
Editor's Picks
Newsletters and Deep Dive
digital magazine